Proposition - PharmXpert Academy

More documents

Recommendations

Info

The Korean Pharmaceutical Company List 445 2. Main Products Information No. The Name of Products Main Ingredient Use (Indications) Formulation The Date of Sales Expected Exporting Countries Etc. 1 Campicil Tab Bacampicillin·H CI 400mg Respiratory, genitourinary tablet 2 Potacin Tab amoxicillin/ clavulanic Acute & chronic bronchitis, lobar & bronchial pneumonia tablet 3 Potacin Syr contains amoxicillin/ potassium clavulanate (7:1) Acute & Chronic bronchitis, lobar & bronchial pneumonia syrup 4 Kukje Cefadroxil Cap Cefadroxil : 500mg Urinary infection, epidermis & skin infection capsule 5 Tricef cap vial contains Cefradine 250mg Tonsillitis, pharyngitis, lobar pneumonia, bronchitis capsule 6 Kukje Gentamicin Inj Gentamicin sulfate 80mg Septicemia, CNS infection, urinary tract injection 7 Kukje Cimetidine Tab Each capsule contains Cimetidine : 200mg Gastroduodenal ulcer, reflux esophagitis, recurrent peptic ulcer, anastomotic ulcer tablet 8 Axadin cap 150mg Each capsule contains Nizatidine : 150mg gastric ulcer, duodenal ulcer capsule 9 Dermakid Cream Prednicarbate Acute and chronic eczema, Atopic eczema, psoriasis, burn cream 10 Nodrowsy Tab Terfenadine Allergic rhinitis, allergic skin disease, pollen-allergies, tablet
446 2007 Korea Pharmaceutical Industry Directory 3. R&D Figures No The Name of Technology Main Ingredient Use (Indications) The Duration of Development The Stage of Development Future Plan Expected Licencing (Domestic, Oversea) 1 DEVELOPMENT OF NEW CHEMICAL ENTITY ANTIBIOTICS CARBAPENEM - KR34008, KR34020 ISSAR 2005 KR34008 & KR34020, A NOVEL 1ß-METHYL CARBAPENEM IN VITRO & VIVO ANTIBACTERIAL ACTIVITY SCREENING, STABILITY TEST FINISHED PRECLINICAL 4. Patent Information No The Name of Technology Application No. (Application date) Publication No. (Publication date) Priority No. Applied Country For Global Development Stage Future Plan Expected Licencing (Domestic, Oversea) 1 Process for preparing (S)-1-acetyl-2- pyrrolidinecarboxamide 2000-0071824 (2000.11.30) 0445781 (2004.08.16) 2 Method of preparing cephem derivatives 10-1995 -0045661 (1995.11.30) 10-0184037 -0000 (1998.12.17) 3 Method of preparing B lactam derivatives 10-1995 -0045662 (1995.11.30) 10-0184036 -0000 (1998.12.17)
Page 2 and 3:
2007 Korea Pharmaceutical Industry
Page 4 and 5:
2007 Korea Pharmaceutical Industry
Page 6 and 7:
27. ILYANG PHARM ·········
Page 8 and 9:
Chapter 1. Outline of The Project 2
Page 10 and 11:
Chapter 1. Outline of The Project 2
Page 12 and 13:
Chapter 2. Pharmaceutical Industry
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
The Annex
Page 38 and 39:
316 2007 Korea Pharmaceutical Indus
Page 40 and 41:
The Korean Pharmaceutical Company L
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
4. Company Map The Korean Pharmace
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117: The Korean Pharmaceutical Company L
Page 200 and 201: 4. Company Map The Korean Pharmace
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
show all

Proposition - PharmXpert Academy

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?